Barclays PLC Bioventus Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Bioventus Inc. stock. As of the latest transaction made, Barclays PLC holds 50,654 shares of BVS stock, worth $540,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,654

Previous 50,654 -0.0%

Holding current value

$540,984

Previous $606,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$5.73 - $11.95 $56,463 - $117,755	9,854 Added 24.15%	50,654 $606,000
Q2 2024 Aug 14, 2024	BUY	$3.96 - $6.93 $25,732 - $45,031	6,498 Added 18.94%	40,800 $235,000
Q1 2024 May 15, 2024	SELL	$4.33 - $5.75 $109,505 - $145,417	-25,290 Reduced 42.44%	34,302 $178,000
Q4 2023 Feb 15, 2024	BUY	$2.89 - $5.34 $67,978 - $125,607	23,522 Added 65.21%	59,592 $314,000
Q3 2023 Nov 07, 2023	BUY	$2.8 - $4.94 $100,996 - $178,185	36,070 New	36,070 $119,000
Q1 2023 May 04, 2023	BUY	$1.07 - $2.95 $10,641 - $29,337	9,945 Added 115.92%	18,524 $20,000
Q4 2022 Feb 13, 2023	BUY	$1.81 - $8.14 $13,102 - $58,925	7,239 Added 540.22%	8,579 $22,000
Q3 2022 Nov 03, 2022	SELL	$6.54 - $9.08 $1,608 - $2,233	-246 Reduced 15.51%	1,340 $9,000
Q2 2022 Aug 12, 2022	SELL	$6.82 - $13.82 $20,234 - $41,003	-2,967 Reduced 65.17%	1,586 $11,000
Q1 2022 May 16, 2022	SELL	$11.65 - $15.28 $343,383 - $450,378	-29,475 Reduced 86.62%	4,553 $65,000
Q4 2021 Feb 14, 2022	BUY	$12.37 - $16.77 $339,742 - $460,588	27,465 Added 418.48%	34,028 $493,000
Q3 2021 Nov 09, 2021	BUY	$13.7 - $17.25 $75,487 - $95,047	5,510 Added 523.27%	6,563 $93,000
Q2 2021 Aug 13, 2021	SELL	$13.75 - $18.8 $89,498 - $122,369	-6,509 Reduced 86.08%	1,053 $19,000
Q1 2021 May 13, 2021	BUY	$11.49 - $19.21 $86,887 - $145,266	7,562 New	7,562 $116,000

Others Institutions Holding BVS

# of Institutions

143

Shares Held

45.9M

Call Options Held

179K

Put Options Held

124K

View Full List

About Bioventus Inc.

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $659M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

More about BVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account